Skip to main content

Table 1 Selected demographic and histologic features of 103 CHL patients

From: Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols

Parameter n (%)
Gender  
 Male 59 (57.3%)
 Female 44 (42.7%)
Mean age 36 years (range: 13–85)
Age ≥ 45 years 28 (27%)
Ann Arbor Stage  
 I 9 (8.7%)
 II 48 (46.6%)
 III 26 (25.2%)
 IV 20 (19.4%)
IPS  
 < 3 83 (80.6%)
 ≥ 3 20 (19.4%)
Radiotherapy  
 No 21 (22.6%)
 Yes 72 (77.4%)
Chemotherapy  
 ABVD 34 (33%)
 ABVD + rituximab 2 (1.94%)
 CVPP/ABDIC 20 (19.4%)
 MOPP/ABVD 3 (2.9%)
 NOVP 44 (42.7%)
CHL Histologic Subtype:  
 Nodular sclerosis 75 (72.8%)
 Mixed cellularity 22 (21.3%)
 Lymphocyte rich 3 (2.9%)
 Lymphocyte depleted 3 (2.9%)